Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.

Abstract

These findings provide strong evidence of the utility of MAOIs in tricyclic-resistant depression, especially in patients with features such as fatigue, volitional inhibition, motoric retardation, hypersomnia, and/or weight gain.